On the viability of tadalafil-based 18F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging

Phosphodiesterase 5 (PDE5) is a clinically relevant biomarker and therapeutic target for many human pathologies, yet a noninvasive agent for the assessment of PDE5 expression has yet to be realized. Such agents would improve our understanding of the nitric oxide (NO)/cyclic guanosine 3′,5′-monophosp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bailey, Justin (VerfasserIn) , Wuest, Melinda (VerfasserIn) , Bojovic, Tamara (VerfasserIn) , Kronemann, Travis (VerfasserIn) , Wängler, Carmen (VerfasserIn) , Wängler, Björn (VerfasserIn) , Wuest, Frank (VerfasserIn) , Schirrmacher, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 August 2021
In: ACS omega
Year: 2021, Jahrgang: 6, Heft: 33, Pages: 21741-21754
ISSN:2470-1343
DOI:10.1021/acsomega.1c03315
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/acsomega.1c03315
Volltext
Verfasserangaben:Justin J. Bailey, Melinda Wuest, Tamara Bojovic, Travis Kronemann, Carmen Wängler, Björn Wängler, Frank Wuest, and Ralf Schirrmacher

MARC

LEADER 00000caa a2200000 c 4500
001 1824494173
003 DE-627
005 20230118160142.0
007 cr uuu---uuuuu
008 221206s2021 xx |||||o 00| ||eng c
024 7 |a 10.1021/acsomega.1c03315  |2 doi 
035 |a (DE-627)1824494173 
035 |a (DE-599)KXP1824494173 
035 |a (OCoLC)1361713831 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bailey, Justin  |e VerfasserIn  |0 (DE-588)1195735537  |0 (DE-627)1677798734  |4 aut 
245 1 0 |a On the viability of tadalafil-based 18F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging  |c Justin J. Bailey, Melinda Wuest, Tamara Bojovic, Travis Kronemann, Carmen Wängler, Björn Wängler, Frank Wuest, and Ralf Schirrmacher 
246 3 3 |a On the viability of tadalafil-based 18 F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging 
264 1 |c 12 August 2021 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist "18" hochgestellt 
500 |a Published online 12 August 2021 
500 |a Gesehen am 06.12.2022 
520 |a Phosphodiesterase 5 (PDE5) is a clinically relevant biomarker and therapeutic target for many human pathologies, yet a noninvasive agent for the assessment of PDE5 expression has yet to be realized. Such agents would improve our understanding of the nitric oxide (NO)/cyclic guanosine 3′,5′-monophosphate (cGMP)/PDE5 pathway in human pathologies and potentially lead to novel uses of PDE5 inhibitors to manage lung conditions like SARS-CoV-2-mediated pulmonary inflammatory responses. In this study, efforts were made to produce an 18F-labeled analogue of the PDE5 inhibitor tadalafil to visualize PDE5 expression in vivo with positron emission tomography (PET). However, during the late-stage fluorination step, quantitative epimerization of the tadalafil C12a stereocenter occurred, yielding a less active epi-isomer. In vivo dynamic microPET images in mice revealed that the epimerized radiotracer, [18F]epi-18, rapidly accumulated in the liver with negligible uptake in tissues of known PDE5 expression. 
700 1 |a Wuest, Melinda  |e VerfasserIn  |4 aut 
700 1 |a Bojovic, Tamara  |e VerfasserIn  |4 aut 
700 1 |a Kronemann, Travis  |e VerfasserIn  |4 aut 
700 1 |a Wängler, Carmen  |d 1978-  |e VerfasserIn  |0 (DE-588)133775593  |0 (DE-627)556368177  |0 (DE-576)30009230X  |4 aut 
700 1 |a Wängler, Björn  |d 1975-  |e VerfasserIn  |0 (DE-588)129702218  |0 (DE-627)477593909  |0 (DE-576)297793888  |4 aut 
700 1 |a Wuest, Frank  |e VerfasserIn  |4 aut 
700 1 |a Schirrmacher, Ralf  |d 1970-  |e VerfasserIn  |0 (DE-588)121796124  |0 (DE-627)705656918  |0 (DE-576)292889518  |4 aut 
773 0 8 |i Enthalten in  |t ACS omega  |d Washington, DC : ACS Publications, 2016  |g 6(2021), 33, Seite 21741-21754  |h Online-Ressource  |w (DE-627)863132308  |w (DE-600)2861993-6  |w (DE-576)474097676  |x 2470-1343  |7 nnas  |a On the viability of tadalafil-based 18F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging 
773 1 8 |g volume:6  |g year:2021  |g number:33  |g pages:21741-21754  |g extent:14  |a On the viability of tadalafil-based 18F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging 
856 4 0 |u https://doi.org/10.1021/acsomega.1c03315  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221206 
993 |a Article 
994 |a 2021 
998 |g 129702218  |a Wängler, Björn  |m 129702218:Wängler, Björn  |d 60000  |d 62900  |e 60000PW129702218  |e 62900PW129702218  |k 0/60000/  |k 1/60000/62900/  |p 6 
998 |g 133775593  |a Wängler, Carmen  |m 133775593:Wängler, Carmen  |d 60000  |d 62900  |e 60000PW133775593  |e 62900PW133775593  |k 0/60000/  |k 1/60000/62900/  |p 5 
999 |a KXP-PPN1824494173  |e 4225318133 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Justin J. Bailey, Melinda Wuest, Tamara Bojovic, Travis Kronemann, Carmen Wängler, Björn Wängler, Frank Wuest, and Ralf Schirrmacher"]},"note":["Im Titel ist \"18\" hochgestellt","Published online 12 August 2021","Gesehen am 06.12.2022"],"recId":"1824494173","physDesc":[{"extent":"14 S."}],"person":[{"family":"Bailey","display":"Bailey, Justin","given":"Justin","role":"aut"},{"role":"aut","family":"Wuest","display":"Wuest, Melinda","given":"Melinda"},{"given":"Tamara","display":"Bojovic, Tamara","family":"Bojovic","role":"aut"},{"role":"aut","display":"Kronemann, Travis","family":"Kronemann","given":"Travis"},{"role":"aut","given":"Carmen","family":"Wängler","display":"Wängler, Carmen"},{"role":"aut","family":"Wängler","display":"Wängler, Björn","given":"Björn"},{"given":"Frank","display":"Wuest, Frank","family":"Wuest","role":"aut"},{"role":"aut","family":"Schirrmacher","display":"Schirrmacher, Ralf","given":"Ralf"}],"titleAlt":[{"title":"On the viability of tadalafil-based 18 F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging"}],"title":[{"title_sort":"On the viability of tadalafil-based 18F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging","title":"On the viability of tadalafil-based 18F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imaging"}],"origin":[{"dateIssuedDisp":"12 August 2021","dateIssuedKey":"2021"}],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2861993-6"],"issn":["2470-1343"],"eki":["863132308"]},"corporate":[{"display":"American Chemical Society","role":"isb"}],"origin":[{"publisher":"ACS Publications","publisherPlace":"Washington, DC","dateIssuedDisp":"[2016]-"}],"title":[{"title_sort":"ACS omega","title":"ACS omega"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"pages":"21741-21754","text":"6(2021), 33, Seite 21741-21754","volume":"6","issue":"33","year":"2021","extent":"14"},"disp":"On the viability of tadalafil-based 18F-radiotracers for in vivo phosphodiesterase 5 (PDE5) PET imagingACS omega","name":{"displayForm":["American Chemical Society"]},"pubHistory":["Volume 1, issue 1 (July 2016)-"],"recId":"863132308","note":["Gesehen am 25.06.2025"]}],"id":{"doi":["10.1021/acsomega.1c03315"],"eki":["1824494173"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a BAILEYJUSTONTHEVIABI1220